The Evolution of Pharma Marketing: KOL Mapping and Sentiment Analysis in the 21st Century
In today’s dynamic healthcare landscape, relying solely on syndicated Key Opinion Leader (KOL) databases is no longer sufficient for pharmaceutical companies aiming to establish themselves as industry leaders. As disease management evolves and personalized treatment regimens become the norm, the need for real-time data and insights about KOLs has become paramount.